Table 2 Patients treated with recurrent disease after previous curative surgery for gallbladder cancer (n = 8).

female,49

TxNxM0

non anatomical liver resection after previous open CHE, no lymph dissection, no exploration of CBD

22

icterus

hepaticojejunostomy

40 months later alive

male, 69

T2NxM0

non anatomical liver resection after previous open CHE, no lymph dissection, no exploration of CBD

6

liver metastases seg. VII, tumour recurrence seg. IV/V

bisegmentectomy seg. IVb/V, cryotherapy seg. VII

died 4 months later

female,69

T2N1M0

non anatomical liver resection Seg. IVb after previous laparoscopic CHE, radical lymph dissection, excision of port sites and tumour free resection margins CBD

12

icterus

seg. III-bypass, gastroenterostomy

died 3 months later

male, 72

T2NxM0

T2 GBC after open CHE, no completion operation

23

tumour between hepaticoduodenal lig. and pancreas

exploration

died 6 months later

female, 68

T3N1M0

anatomical liver resection Seg. IVb/V after open CHE, lymph dissection, no tumour free resection margin CBD

3

gastric stenosis, liver abscess

interventional abscess drainage, implantation venous port system

died 1 month later

male, 64

T3NxM0

anatomical liver resection Seg. IVb/V after open CHE, no lymph dissection, tumour free resection margin CBD

1

duodenal stenosis

gastroenterostomy

died 1 month later

female, 60

T3NxM0

bisegmentectomy seg. IVb/V en bloc with CHE, no lymph dissection tumour free resection margin of CBD,

11

skin metastasis

resection

died 13 months later

male, 74

T4NxM0

non-anatomical wedge resection of seg. IVb during CHE, no lymph dissection, no tumour free resection margin of CBD

2

tumour progress with liver infiltration

cryotherapy

lost for follow up